Skip to main content
Clinical Trials/NCT04744259
NCT04744259UnknownNot Applicable

Behavioural Activation (BeatIt) for Depression in Adults With Severe Intellectual Disabilities. A Feasibility Randomised Controlled Study of BeatIt Versus Treatment as Usual

NHS Greater Glasgow and Clyde1 site in 1 country30 target enrollmentStarted: February 18, 2019Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
30
Locations
1
Primary Endpoint
Change from baseline on the Mood, Interest and Pleasure Questionnaire (MIPQ) at 24 weeks

Study Overview

Brief Summary

Depression is common, but no psychological interventions have been tested to see if they work for adults with severe intellectual disabilities. The research team recently successfully completed a full-scale trial of a psychological intervention, BeatIt, for depressed adults with mild/moderate intellectual disabilities. The aim of this study is to comprehensively evaluate the feasibility of modifying BeatIt for depressed adults with severe intellectual disabilities, collecting the information needed on likely recruitment, measures, and waiting list control arm options, to design a full-scale study.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Severe/profound intellectual disabilities
  • •18 years old and over
  • •Clinically significant unipolar depression
  • •Has a family member or paid carer who has supported them for a minimum of 6 months to complete the screening and baseline visits OR is able to obtain information for the previous 4 months prior to randomisation. The carer, or another named individual, should be available for weekly-fortnightly treatment sessions with the practitioner, and should currently provide a minimum of 10 hours support per week to the participant.

Exclusion Criteria

  • •Mild/moderate intellectual disabilities
  • •Factors that prevent the person from interacting with the carer and therapist or retaining information from the therapy (e.g. late stage dementia, significant agitation, withdrawal arising from psychosis)
  • •Does not consent to her/his GP being contacted about their participation in the study.

Arms & Interventions

Behavioural activation

Experimental

The treatment is designed to be delivered to individuals alongside a carer who provides regular support to them. It is a structured, time limited, manualised psychological therapy, developed to treat those with an intellectual disability and depressive symptoms.

Intervention: Behavioural Activation (Behavioral)

Treatment as usual

No Intervention

This will include the existing treatments available in NHS and social care for adults with intellectual disability with depression, including anti-depressants, mood stabilizers, and any available psychological interventions. Additionally, for all those in the study, we will provide their General Practitioner with a summary of the NICE guidelines on treatment of depression for adults with intellectual disabilities.

Outcomes

Primary Outcomes

Change from baseline on the Mood, Interest and Pleasure Questionnaire (MIPQ) at 24 weeks

Time Frame: Baseline and week 24

A measure of the individuals mood and engagement in activities. The score range for each sub-scale is 0 - 24. Total score range is 0 - 48. Lower scores indicate lower mood and lower levels of interest and pleasure (within the last 2 week)

Change from baseline on Intellectual Disabilities Depression Scale (IDDS) at 24 weeks

Time Frame: Baseline and week 24

This is a 38-item behavioural checklist derived from DSM-III-R criteria, designed to measure the frequency of identified depressive behaviours within a four-week period. Each item is scored on a 7-point Likert scale from 0 (never) to 6 (always). All scores are summed to provide a total score, ranging from 0 to 228. Higher scores indicate a higher frequency of depressive symptoms.

Secondary Outcomes

  • Change from baseline on the Anxiety, Depression and Mood Scale at 24 weeks(Baseline and week 24)
  • Change from baseline on the Modified Index of Community Involvement (ICI) at 24 weeks(Baseline and week 24)
  • Change from baseline on the Modified Index of Domestic Participation at 24 weeks(Baseline and week 24)
  • Change from baseline on the Emotional Difficulties self-efficacy scale at 24 weeks(Baseline and week 24)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials